| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9346153 | Ophthalmology | 2005 | 8 Pages |
Abstract
The fluocinolone acetonide intravitreal implant effectively controlled intraocular inflammation in the studied population. Elevated IOP and cataracts that occurred in fluocinolone device-implanted eyes were managed by standard means. The fluocinolone acetonide sustained drug delivery implant seems to be promising in patients with posterior uveitis who do not respond to or are intolerant to conventional treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Glenn J. MD, Rex M. MD, Brenda COT, Cindy RN, COT, Zuhal OD, MS, Paul PhD,